Physician

David C Thornton, MD

According to 2025 Medicare claims, David Thornton, MD (NPI: 1265472773) practices pulmonary disease in the Pinehurst-Southern Pines, NC market, with the plurality of this provider's patient population coming from Moore, NC. This provider's primary affiliated billing organization is PINEHURST MEDICAL CLINIC, INC. (NPI: 1255388369; TIN: 560942980) and primary practice location at 28374-8749. Thornton is affiliated with the agilon health Mid-Atlantic ACO, Inc. (DBA: Senior Health Connect ACO 5) (ACO ID: D0156), participating under the REACH model.

Thornton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 963 traditional Medicare patients, billed 8,158 HCPCS/CPT codes, and received $316,278 in Medicare payments. The top billing code was 94729 (Test to examine how well the lungs exchange gases). Part D data shows 26 prescription claims across 17 beneficiaries totaling $6,090 in drug costs. DME data shows 447 claims. Open Payments data shows 81 records totaling $1,762. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $696,440 to $316,278. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $575,633 to $6,090. For DME billing, reported payments started with an early spike, then settled into a lower baseline, moving from $210,703 to $39,721.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,644	31,575	$696,440
2016	1,708	25,780	$708,411
2017	1,481	19,940	$588,165
2018	1,324	17,140	$545,444
2019	1,266	14,669	$457,799
2020	1,041	14,091	$358,823
2021	1,107	15,313	$403,630
2022	1,080	11,028	$425,470
2023	980	15,223	$501,517
2024	963	8,158	$316,278

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	124	402	$575,633
2016	132	353	$413,326
2017	144	640	$452,542
2018	84	315	$243,474
2019	65	285	$197,109
2020	37	148	$101,229
2021	39	112	$170,822
2022	21	57	$70,998
2023	28	55	$10,291
2024	17	26	$6,090

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	605	2,024	$236,589
2016	639	1,969	$168,574
2017	499	1,413	$60,798
2018	405	1,064	$70,291
2019	345	837	$67,575
2020	374	925	$79,275
2021	307	796	$97,368
2022	216	556	$66,380
2023	300	809	$149,897
2024	61	447	$100,244

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
94729	Test to examine how well the lungs exchange gases	440	491	$37
94726	Test to determine lung volumes using sensors	315	318	$36
94375	Test to measure rate of airflow	257	310	$26
94060	Test to measure expiratory airflow and volume changes before and after medication administration	257	260	$25
71046	X-ray of chest, 2 views	263	331	$15

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	11	$53,845
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	14	$14,295
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	18	125	$11,446
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	11	$8,382
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	11	$1,806

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	81	$1,762	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David C. Thornton, MD?

Tedicare shows public-source Medicare data for David C. Thornton, MD (NPI 1265472773), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David C. Thornton, MD have ACO affiliation data?

David C. Thornton, MD is shown with ACO affiliation data for agilon health Mid-Atlantic ACO, Inc. (DBA: Senior Health Connect ACO 5) (REACH, ACO ID D0156).

What billing organization is linked to David C. Thornton, MD?

David C. Thornton, MD is linked to PINEHURST MEDICAL CLINIC, INC. (billing NPI 1255388369) in the available physician profile data.

Does David C. Thornton, MD have Open Payments data?

David C. Thornton, MD has 81 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.